DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Sagopilone is an investigational drug.
There have been 13 clinical trials for Sagopilone. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2005.
The most common disease conditions in clinical trials are Lung Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Bayer, Breast Cancer Research Foundation, and European Organisation for Research and Treatment of Cancer - EORTC.
Recent Clinical Trials for Sagopilone
|Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)||Bayer||Phase 2|
|ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases||Bayer||Phase 2|
|ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases||Breast Cancer Research Foundation||Phase 2|